ESPRIVA, created in 2011 (United States), from 2466 sister brands and 17477 competing brands. ESPRIVA is owned by JOHNSON & JOHNSON, listed on the stock exchange of New York ESPRIVA belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(ESPRIVA)
over 5 years*
USD 151.47